Oxcarbazepine Range

Oxcarbazepine PCD Pharma Franchise Company

Cafoli Lifecare is a dependable Oxcarbazepine PCD pharma franchise company in India, offering 6 Oxcarbazepine formulations in tablet form within its neuro-psychiatry portfolio. Every batch is manufactured at WHO-GMP certified, DCGI-approved facilities, and franchise partners receive exclusive district-wise monopoly rights.

What is Oxcarbazepine?

Oxcarbazepine is an antiepileptic drug and a structural analogue of carbamazepine. It is a prodrug, rapidly converted to its active metabolite licarbazepine, which blocks voltage-gated sodium channels in hyperexcited neurons. By stabilising these membranes it suppresses the repetitive neuronal firing that propagates a seizure. Compared with carbamazepine it induces hepatic enzymes to a lesser degree, which reduces the burden of drug interactions. It is indicated for partial-onset seizures, with or without secondary generalisation, in adults and children. It is listed on the WHO Model List of Essential Medicines.

Available Oxcarbazepine Formulations

The Cafoli Lifecare Oxcarbazepine range comprises 6 formulations, available in the following dosage form:

• Tablets

Brand names, compositions, pack sizes and net rates are shared with registered franchise enquiries. Contact our team for the current Oxcarbazepine price list.

Therapeutic Applications of Oxcarbazepine

Prescribed under specialist supervision for:

• Partial-onset (focal) seizures, as monotherapy or adjunctive therapy
• Partial seizures with secondary generalisation
• Paediatric focal epilepsy, under a paediatric neurologist
• Trigeminal neuralgia and mood stabilisation, in selected patients under specialist care

Prescriber specialties: neurologists, psychiatrists, paediatric neurologists and consulting physicians.

Safety note: Oxcarbazepine is a prescription-only medicine that must be initiated and titrated by a specialist. It should never be stopped abruptly, requires monitoring for hyponatraemia, and carries a recognised risk of serious hypersensitivity reactions. It must be promoted strictly within its approved indications.

Why Oxcarbazepine is a High-Potential Molecule for Distributors

Antiepileptics are the stickiest business in pharma, and Oxcarbazepine is a good illustration of why. Once a neurologist finds a regimen that achieves seizure control, neither doctor nor patient will risk changing it — the downside of a breakthrough seizure is measured in driving licences and jobs, not rupees. The result is extraordinary prescription persistence: a patient initiated on Oxcarbazepine typically continues for years, often for life, and brand switching at the chemist counter is actively resisted. India has a very large epilepsy population, and Oxcarbazepine has been steadily gaining ground over older agents like carbamazepine and phenytoin because of its cleaner interaction profile. The prescriber base is also tiny and concentrated — a district may have only a handful of neurologists — so coverage costs are minimal relative to the lifetime value of each patient won. The one non-negotiable is supply: this segment rewards distributors who never run out.

Why Choose Cafoli Lifecare

• Monopoly rights — exclusive district-wise marketing rights for the Oxcarbazepine range
• WHO-GMP certified manufacturing and DCGI-approved products
• Promotional inputs — visual aids, MR bags, prescription pads, samples and reminder cards
• 1000+ franchise partners across India with an on-time dispatch record
• Transparent net rates and dedicated franchise support

References

1. WHO Model List of Essential Medicines
2. PubChem — Oxcarbazepine compound record
3. PubMed — Oxcarbazepine in partial-onset seizures